CING 内幕交易
CING 的 SEC Form 4 内幕交易记录
总交易
41
买入
10
买入总额
$667K
卖出总额
-
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(45) | SCHAFFER SHANE J. | Chief Executive Officer | 买入 | 6,809 | $5.04 | $34K | 2026-02-06 | CEO买入, 董事买入 |
| ★★★★★(45) | SCHAFFER SHANE J. | Chief Executive Officer | 买入 | 5,447 | $0.10 | $545 | 2026-02-06 | CEO买入, 董事买入 |
| ★★★★★(25) | HARGROVES THOMAS JEFFREY | - | 买入 | 97,276 | $5.04 | $490K | 2026-02-13 | 董事买入, 买入>$100K |
| ★★★★★(25) | CALLAHAN JENNIFER L. | SVP and CFO | 买入 | 3,891 | $0.10 | $389 | 2026-02-06 | CFO买入 |
| ★★★★★(25) | CALLAHAN JENNIFER L. | SVP and CFO | 买入 | 4,864 | $5.04 | $25K | 2026-02-06 | CFO买入 |
| ★★★★★(15) | HARGROVES THOMAS JEFFREY | - | 买入 | 77,821 | $0.10 | $8K | 2026-02-13 | 董事买入 |
| ★★★★★(15) | WERTH PETER J. | - | 买入 | 19,455 | $5.04 | $98K | 2026-02-06 | 董事买入 |
| ★★★★★(15) | WERTH PETER J. | - | 买入 | 15,564 | $0.10 | $2K | 2026-02-06 | 董事买入 |
| ★★★★★(10) | BRAMS MATTHEW | EVP and Chief Medical Officer | 买入 | 1,556 | $0.10 | $156 | 2026-02-06 | 高管买入 |
| ★★★★★(10) | BRAMS MATTHEW | EVP and Chief Medical Officer | 买入 | 1,946 | $5.04 | $10K | 2026-02-06 | 高管买入 |
| ★★★★★(0) | SILVA RAUL R. | EVP and CSO | 卖出 | 4,293 | - | - | 2026-09-30 | |
| ★★★★★(0) | BRAMS MATTHEW | EVP and Chief Medical Officer | 卖出 | 26,400 | - | - | 2026-07-16 | |
| ★★★★★(0) | BRAMS MATTHEW | EVP and Chief Medical Officer | 卖出 | 53,600 | - | - | 2026-07-16 | |
| ★★★★★(0) | SILVA RAUL R. | EVP and CSO | 卖出 | 26,400 | - | - | 2026-07-16 | |
| ★★★★★(0) | SCHAFFER SHANE J. | Chief Executive Officer | 卖出 | 97,350 | - | - | 2026-07-16 | |
| ★★★★★(0) | HARGROVES THOMAS JEFFREY | - | 卖出 | 20,000 | - | - | 2026-07-16 | |
| ★★★★★(0) | CALLAHAN JENNIFER L. | EVP and CFO | 卖出 | 19,800 | - | - | 2026-07-16 | |
| ★★★★★(0) | DOWNEY BRYAN WADE | EVP & Chief Commercial Officer | 卖出 | 33,000 | - | - | 2026-07-16 | |
| ★★★★★(0) | SILVA RAUL R. | EVP and CSO | 卖出 | 53,600 | - | - | 2026-07-16 | |
| ★★★★★(0) | CALLAHAN JENNIFER L. | EVP and CFO | 卖出 | 40,200 | - | - | 2026-07-16 | |
| ★★★★★(0) | SCHAFFER SHANE J. | Chief Executive Officer | 卖出 | 197,650 | - | - | 2026-07-16 | |
| ★★★★★(0) | WERTH PETER J. | - | 卖出 | 20,000 | - | - | 2026-07-16 | |
| ★★★★★(0) | LAWRENCE BRYAN JAY | - | 卖出 | 20,000 | - | - | 2026-07-16 | |
| ★★★★★(0) | DOWNEY BRYAN WADE | EVP & Chief Commercial Officer | 卖出 | 67,000 | - | - | 2026-07-16 | |
| ★★★★★(0) | SILVA RAUL R. | EVP and CSO | 卖出 | 3,885 | - | - | 2026-06-30 | |
| ★★★★★(0) | HARGROVES THOMAS JEFFREY | - | 卖出 | 15,000 | - | - | 2026-03-09 | |
| ★★★★★(0) | HARGROVES THOMAS JEFFREY | - | 卖出 | 0 | - | - | 2026-02-13 | |
| ★★★★★(0) | SILVA RAUL R. | EVP and CSO | 卖出 | 3,422 | - | - | 2026-03-31 | |
| ★★★★★(0) | CALLAHAN JENNIFER L. | EVP and CFO | 卖出 | 6,427 | - | - | 2026-03-09 | |
| ★★★★★(0) | PATEL NILAY DAHYABHAI | EVP, CLO and CCO | 卖出 | 5,475 | - | - | 2026-03-09 | |
| ★★★★★(0) | SCHAFFER SHANE J. | Chief Executive Officer | 卖出 | 0 | - | - | 2026-03-09 | |
| ★★★★★(0) | BRAMS MATTHEW | EVP and Chief Medical Officer | 卖出 | 4,526 | - | - | 2026-03-09 | |
| ★★★★★(0) | BRAMS MATTHEW | EVP and Chief Medical Officer | 卖出 | 1,025 | - | - | 2026-03-09 | |
| ★★★★★(0) | SILVA RAUL R. | EVP and CSO | 卖出 | 1,828 | - | - | 2026-03-09 | |
| ★★★★★(0) | PATEL NILAY DAHYABHAI | EVP, CLO and CCO | 卖出 | 2,086 | - | - | 2026-03-09 | |
| ★★★★★(0) | SILVA RAUL R. | EVP and CSO | 卖出 | 4,526 | - | - | 2026-03-09 | |
| ★★★★★(0) | CALLAHAN JENNIFER L. | EVP and CFO | 卖出 | 15,329 | - | - | 2026-03-09 | |
| ★★★★★(0) | SCHAFFER SHANE J. | Chief Executive Officer | 卖出 | 6,862 | - | - | 2026-03-09 | |
| ★★★★★(0) | SCHAFFER SHANE J. | Chief Executive Officer | 卖出 | 2,959 | - | - | 2026-03-09 | |
| ★★★★★(0) | WERTH PETER J. | - | 卖出 | 0 | - | - | 2026-02-06 | |
| ★★★★★(0) | SCHAFFER SHANE J. | Chief Executive Officer | 卖出 | 0 | - | - | 2026-02-06 |